Cargando…

Transcriptomic classification of genetically engineered mouse models of breast cancer identifies human subtype counterparts

BACKGROUND: Human breast cancer is a heterogeneous disease consisting of multiple molecular subtypes. Genetically engineered mouse models are a useful resource for studying mammary cancers in vivo under genetically controlled and immune competent conditions. Identifying murine models with conserved...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pfefferle, Adam D, Herschkowitz, Jason I, Usary, Jerry, Harrell, Joshua Chuck, Spike, Benjamin T, Adams, Jessica R, Torres-Arzayus, Maria I, Brown, Myles, Egan, Sean E, Wahl, Geoffrey M, Rosen, Jeffrey M, Perou, Charles M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4053990/ https://www.ncbi.nlm.nih.gov/pubmed/24220145 http://dx.doi.org/10.1186/gb-2013-14-11-r125

Ejemplares similares

Luminal progenitor and fetal mammary stem cell expression features predict breast tumor response to neoadjuvant chemotherapy
por: Pfefferle, Adam D., et al.
Publicado: (2015)

Genomic profiling of murine mammary tumors identifies potential personalized drug targets for p53-deficient mammary cancers
por: Pfefferle, Adam D., et al.
Publicado: (2016)

Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
por: Prat, Aleix, et al.
Publicado: (2010)

The MMTV-Wnt1 murine model produces two phenotypically distinct subtypes of mammary tumors with unique therapeutic responses to an EGFR inhibitor
por: Pfefferle, Adam D., et al.
Publicado: (2019)

The functional loss of the retinoblastoma tumour suppressor is a common event in basal-like and luminal B breast carcinomas
por: Herschkowitz, Jason I, et al.
Publicado: (2008)

Endothelial-like properties of claudin-low breast cancer cells promote tumor vascular permeability and metastasis
por: Harrell, J. Chuck, et al.
Publicado: (2013)

A mouse model featuring tissue-specific deletion of p53 and Brca1 gives rise to mammary tumors with genomic and transcriptomic similarities to human basal-like breast cancer
por: Hollern, Daniel P., et al.
Publicado: (2018)

Characterization of cell lines derived from breast cancers and normal mammary tissues for the study of the intrinsic molecular subtypes
por: Prat, Aleix, et al.
Publicado: (2013)

Cell state plasticity, stem cells, EMT, and the generation of intra-tumoral heterogeneity
por: Wahl, Geoffrey M., et al.
Publicado: (2017)

Ror2-mediated alternative Wnt signaling regulates cell fate and adhesion during mammary tumor progression
por: Roarty, K, et al.
Publicado: (2017)

Expression of miR-200c in claudin-low breast cancer alters stem cell functionality, enhances chemosensitivity and reduces metastatic potential
por: Knezevic, Jana, et al.
Publicado: (2015)

Gene expression patterns associated with p53 status in breast cancer
por: Troester, Melissa A, et al.
Publicado: (2006)

Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1
por: Wright, Mollie H, et al.
Publicado: (2008)

Counterparts: Chap. I
Publicado: (1887)

Counterparts: Chap. III
Publicado: (1887)

Counterparts: Chap. II
Publicado: (1887)

Pluralities, counterparts, and groups
por: Wilhelm, Isaac
Publicado: (2022)

“3D Counterpart Analysis”: A Novel Method for Enlow’s Counterpart Analysis on CBCT
por: D’Attilio, Michele, et al.
Publicado: (2022)

The Bunyavirales: The Plant-Infecting Counterparts
por: Kormelink, Richard, et al.
Publicado: (2021)

Radio counterparts to extreme X-ray YSOs
por: Smith, K, et al.
Publicado: (1999)

Electromagnetic counterparts to massive black-hole mergers
por: Bogdanović, Tamara, et al.
Publicado: (2022)

Tailored therapies based upon tumor subtype biology
por: Perou, CM
Publicado: (2005)

Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer
por: O’Flanagan, Ciara H., et al.
Publicado: (2017)

Genomic analysis identifies unique signatures predictive of brain, lung, and liver relapse
por: Harrell, J. Chuck, et al.
Publicado: (2011)

Lgr5 is a marker for fetal mammary stem cells, but is not essential for stem cell activity or tumorigenesis
por: Trejo, Christy L., et al.
Publicado: (2017)

Stereoscopic depth constancy for physical objects and their virtual counterparts
por: Hartle, Brittney, et al.
Publicado: (2022)

Metaphors are Embodied, and so are Their Literal Counterparts
por: Santana, Eduardo, et al.
Publicado: (2011)

Ageing of the human metaorganism: the microbial counterpart
por: Biagi, Elena, et al.
Publicado: (2011)

Counterparts: Chap. IV. A Discovery
Publicado: (1887)

Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors
por: Herschkowitz, Jason I, et al.
Publicado: (2007)

Universal Reference RNA as a standard for microarray experiments
por: Novoradovskaya, Natalia, et al.
Publicado: (2004)

The heterotic string and supersymmetric counterparts of the Lorentz Chern-Simons terms
por: Daniel, M, et al.
Publicado: (1986)

The safety of lookalikes: a new THC beverage enhancer and a non-THC counterpart
por: Brown, Geoffrey W., et al.
Publicado: (2023)

Classical potential theory and its probabilistic counterpart
por: Doob, Joseph L
Publicado: (2001)

Classical potential theory and its probabilistic counterpart
por: Doob, J L
Publicado: (1984)

X(3872) and its bottomonium counterpart at ATLAS
por: Kordas, Kostantinos
Publicado: (2016)

X(3872) and its bottomonium counterpart at ATLAS
por: Kordas, Kostantinos
Publicado: (2016)

Acanthamoeba and bacteria produce antimicrobials to target their counterpart
por: Iqbal, Junaid, et al.
Publicado: (2014)

No Counterpart of Visual Perceptual Echoes in the Auditory System
por: İlhan, Barkın, et al.
Publicado: (2012)

Multiple glioblastomas: Are they different from their solitary counterparts?
por: Singh, Gajendra, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_j1adlou5ff49mj7chaihjfb8js